Blog

ReNeuron gets ‘orphan drug’ status
Scotsman
ReNeuron, the Aim-quoted life sciences outfit that tests its products at hospitals in Dundee and Glasgow, was yesterday awarded “orphan drug” status for its experimental stem cell treatment for eye diseases. The move could help attract grant funding …

and more